Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty

被引:0
作者
Y.-Y. Tseng
C.-H. Su
T.-N. Lui
Y.-S. Yeh
S.-H. Yeh
机构
[1] Shuang Ho Hospital,Department of Neurosurgery
[2] Taipei Medical University,Department of Neurosurgery
[3] Wan Fang Hospital,Department of Neurosurgery
[4] Taipei Medical University,undefined
[5] Chang Gung Memorial Hospital,undefined
[6] Chiayi & Chang Gung University,undefined
来源
Osteoporosis International | 2012年 / 23卷
关键词
Adjacent vertebral fracture; Antiresorptive agent; Teriparatide; Vertebral compression fracture; Vertebroplasty;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1613 / 1622
页数:9
相关论文
共 304 条
[1]  
Hall SE(1999)A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture Osteoporos Int 9 508-515
[2]  
Criddle RA(2006)Osteoporosis Lancet 367 2010-2018
[3]  
Comito TL(2006)Percutaneous vertebroplasty as a treatment for osteoporotic vertebral compression fractures: a systematic review Eur Spine J 15 1749-1758
[4]  
Prince RL(2009)Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population-based cohort study Osteoporos Int 20 819-826
[5]  
Sambrook P(2007)Adjacent vertebral failure after vertebroplasty: a biomechanical study of low-modulus PMMA cement Eur Spine J 16 2118-2125
[6]  
Cooper C(2006)New fractures after vertebroplasty: adjacent fractures occur significantly sooner Ajnr 27 217-223
[7]  
Ploeg WT(2006)The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty J Vasc Interv Radiol 17 71-76
[8]  
Veldhuizen AG(2009)Repeated and multiple new vertebral compression fractures after percutaneous transpedicular vertebroplasty Spine 34 1917-1922
[9]  
The B(1996)Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1535-1541
[10]  
Sietsma MS(1999)Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators Jama 282 637-645